BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23274042)

  • 1. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
    Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.
    Lie Fong S; Lugtenburg PJ; Schipper I; Themmen AP; de Jong FH; Sonneveld P; Laven JS
    Hum Reprod; 2008 Mar; 23(3):674-8. PubMed ID: 18216040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
    J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen.
    Tuan Dat D; Huyen Thuong PT; Hong Hai D; Khac Toan N; Tai Duc N; Duy Anh N; Thi Thu Ha N
    Clin Ter; 2024; 175(2):128-134. PubMed ID: 38571471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian Hormone in Patients Treated with Chemotherapy for Gestational Trophoblastic Neoplasia Does Not Predict Short-Term Fertility.
    Ghorani E; Ramaswami R; Smith RJ; Savage PM; Seckl MJ
    J Reprod Med; 2016; 61(5-6):205-9. PubMed ID: 27424359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
    Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
    Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels.
    Benian A; Guralp O; Uzun DD; Okyar A; Sahmay S
    Gynecol Endocrinol; 2013 Mar; 29(3):226-9. PubMed ID: 23428228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone as a marker of ovarian reserve in patients with ovarian malignancies who have undergone fertility-preserving surgery and chemotherapy.
    Iwase A; Sugita A; Hirokawa W; Goto M; Nakahara T; Bayasula ; Kajiyama H; Shibata K; Nagatomo Y; Kikkawa F
    Gynecol Endocrinol; 2013 Apr; 29(4):357-60. PubMed ID: 23305483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
    Zhou Y; Feng FZ; Xiang Y; Wan XR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis.
    Brouwer J; Laven JS; Hazes JM; Schipper I; Dolhain RJ
    Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1534-8. PubMed ID: 23554429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia.
    Zamani M; Mohsenpour F; Torkzaban F; Atrvash N; Majlesi A; Torkzaban A
    J Reprod Infertil; 2023; 24(1):43-48. PubMed ID: 36919051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Berteloot P; Vergote I
    Gynecol Oncol; 2012 Oct; 127(1):47-50. PubMed ID: 22705360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
    Lybol C; Centen DW; Thomas CM; ten Kate-Booij MJ; Verheijen RH; Sweep FC; Ottevanger PB; Massuger LF
    BJOG; 2012 Nov; 119(12):1465-72. PubMed ID: 22925191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay.
    Decanter C; Peigne M; Mailliez A; Morschhauser F; Dassonneville A; Dewailly D; Pigny P
    Fertil Steril; 2014 Aug; 102(2):483-7. PubMed ID: 24951363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia.
    Wong JM; Liu D; Lurain JR
    J Reprod Med; 2014; 59(5-6):204-8. PubMed ID: 24937958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.